Treatment of aggressive prostate cancer with triptorelin in real life in France: the TALISMAN study
Authors
- Thierry Lebrét (ORCID: https://orcid.org/0000-0002-8664-3861)
- J. Rigaud (ORCID: https://orcid.org/0000-0003-2845-9019)
- G. Créhange (ORCID: https://orcid.org/0000-0002-7127-9323)
- N. Pello-Leprince-Ringuet
- Valérie Perrot (ORCID: https://orcid.org/0000-0002-5541-728X)
Institutions
- Ipsen (France) (FR)
- Hôpital Foch (FR)
- Institut Curie (FR)
Publication Details
- Journal
- Therapeutic Advances in Urology
- Published
- 2025-10-15
- DOI
- https://doi.org/10.1177/17562872251382970
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00